News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
The NIH is aiming to fund projects evaluating the clinical potential of cancer biomarker assays that are already validated for research use.
DxTerity aims to develop a genomic blood test to identify which cancer patients are most likely to benefit from radiation therapy or are at risk for toxicity.
Inflammatix hopes to market an 18-gene panel that will be able to tell from a blood sample whether a hospitalized patient has a bacterial, viral, or no infection.
The partners aim to identify microRNAs that can be used to identify patients likely to respond to PD-L1-targeting cancer drugs.
The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma.